ClinicalTrials.gg
RecruitingNCT07402642Updated Feb 11, 2026

Effect of Early Educational Intervention on Cardiovascular Risk Factors After Acute Coronary Syndrome

An interventional study of Motivational and Individualized Interviewing and Heart-Healthy Dietary Education in Myocardial Infarction, sponsored by Sergio Mies Padilla. Recruiting at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-11.

Sponsored by Sergio Mies Padilla · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Started Jan 2026; still recruiting 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
256
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 131 studies in Myocardial Infarction with a site in Spain — 19 open to participants now, 27 under way, 7 of them phase 3. Myocardial Infarction · Spain.

Planned enrollment
65th of 98
256 · median 445
Started
2026
with 3 others
No phase
29 of 131
5 open now
Primary completion
2027-01
later than 11 of 26 live
Registered
128th of 131
by date

Among the 131 studies in Myocardial Infarction with a site in Spain, this one is the 65th largest by planned enrollment of the 98 interventional ones that give a count, is one of 4 that started in 2026, is one of 29 with no phase, reaches primary completion later than 11 of the 26 other live ones, and was the 128th registered.

Myocardial Infarction

2,273 studies on the registry are indexed under Myocardial Infarction; 373 are open to participants now.

Browse Myocardial Infarction studies →

Open to participants now

19 of the 131 studies in Myocardial Infarction with a site in Spain are open now. Recruiting first, the newest first:

13 more — sign in →

All 19 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 256 Myocardial Infarction studies recruiting now, 173 (68%) set no upper age limit and 25 (10%) stop at 75 or younger; 17 take children under 18; 27 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 131 studies in Myocardial Infarction with a site in Spain, or all of them as a file.
02

Study summary

Early Education After a Heart Attack What is the purpose of this study? The main goal is to evaluate if a special nursing education and support program helps patients who have suffered a heart attack feel more confident in managing their own health. Researchers want to see if this extra support improves how patients care for their hearts through diet, physical activity, and quitting smoking. The study compares this new nursing strategy against the standard care patients usually receive.

Who can participate? Participants must be 18 years of age or older. People who have recently had a heart attack requiring an urgent heart catheterization at the Complejo Hospitalario Universitario Insular Materno Infantil.

Exclusions: People with significant language barriers (Spanish), mental incapacity to follow recommendations, or those unable to attend in-person consultations cannot participate.

What will happen during the study? Participants will be divided into two groups: Standard Care Group (Control): These participants will receive the usual medical follow-up and standard cardiac rehabilitation sessions (an average of 17 sessions focused on exercise and group education). Special Support Group (Experimental): In addition to standard care, these participants will have a specific nursing consultation consisting of 4 scheduled visits.

These visits are a mix of in-person and telephone appointments.Nurses will provide personalized educational materials, such as infographics, and teach techniques to control blood pressure, improve diet, exercise safely, and manage emotions after a heart attack.

Duration and Follow-up Each participant will be followed for approximately 8 months. During this time, they will be asked to complete several surveys about their lifestyle.

Researchers will also review blood test results (cholesterol levels) from their medical records to track progress.

03

Conditions studied

  • Myocardial Infarction

Keywords

  • Patient Education
  • Secondary Prevention
  • Nursing Care
  • Self Efficacy
  • risk factors
  • Healthy Lifestyle
  • Cardiovascular Diseases
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients must have suffered an Acute Myocardial Infarction.
  • Participants must have undergone an urgent cardiac catheterization.
  • Specifically, this includes patients who received coronary reperfusion strategies following the activation of the CODICAN protocol (assistance for ST-segment elevation myocardial infarction) within the study environment.

Exclusion criteria

Exclusion Criteria:

  • Patients with little or no knowledge of the Spanish language that prevents effective communication or reading of educational resources.
  • Patients unable to understand their participation or follow health recommendations independently.
  • Patients with an unfavorable clinical prognosis or those requiring hospitalization for a period exceeding established limits.
  • Patients unable to attend in-person nursing consultations due to personal reasons or place of residence
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
256 participants (estimated)

Study arms

  • Experimental
    Experimental Group

    The intervention for the experimental group consists of specialized and structured nursing care provided in addition to standard medical treatment. This program is organized into four key stages: it begins with an initial contact during hospital admission to explain the objectives and assess baseline risks. Subsequently, between 7 and 10 days after discharge, a 60-minute in-person visit is conducted to perform a complete medical history and deliver adapted educational materials on heart-healthy habits. Four months after the event, a telephone reinforcement session is held to monitor treatment adherence and lifestyle changes. Finally, eight months after discharge, an in-person evaluation is carried out to measure the achievement of goals and, if necessary, refer the patient to other specialists. The entire process is supported by the use of infographics and evidence-based educational materials focused on blood pressure control, diet, exercise, and emotional health.

    Behavioral: Motivational and Individualized Interviewing · Behavioral: Heart-Healthy Dietary Education · Behavioral: Tobacco Cessation Approach · Behavioral: Physical Activity Promotion · Behavioral: Emotional Health Management · Behavioral: Therapeutic Adherence Reinforcement · Behavioral: Self-Control Training · Behavioral: Use of Educational Resources · Other: Cardiac Rehabilitation Program

  • Active comparator
    Control Group

    The Control Group consists of patients who receive the standard healthcare provided by the hospital after a heart attack. These participants are recruited retrospectively using the hospital's hemodynamic service records. After discharge, they participate in the standard cardiac rehabilitation program, which typically includes 17 sessions of physical exercise and group health education. Their data is collected through a single telephone interview approximately 8 months after their heart attack to evaluate their lifestyle habits, emotional state, and clinical progress.

    Other: Cardiac Rehabilitation Program

Interventions

  • BehavioralMotivational and Individualized Interviewing

    Used to verify the patient's understanding of their condition and to motivate behavioral changes.

  • BehavioralHeart-Healthy Dietary Education

    Specific counseling to improve adherence to the Mediterranean diet and address overweight or obesity

  • BehavioralTobacco Cessation Approach

    Interventions aimed at increasing motivation to quit smoking and reducing nicotine dependence

  • BehavioralPhysical Activity Promotion

    Personalized exercise recommendations tailored to the patient's clinical status

  • BehavioralEmotional Health Management

    Professional support to address emotional well-being, detecting potential states of anxiety or depression following the acute event.

  • BehavioralTherapeutic Adherence Reinforcement

    Continuous education and monitoring to ensure compliance with the prescribed pharmacological plan

  • BehavioralSelf-Control Training

    Training the patient for autonomous monitoring of risk factors, such as blood pressure

  • BehavioralUse of Educational Resources

    Provision of adapted materials (infographics and written documents) to permanently reinforce healthy knowledge and behaviors

  • OtherCardiac Rehabilitation Program

    Upon hospital discharge, all patients are referred to a cardiac rehabilitation unit. The program consists of an average of 17 sessions focused primarily on the physical rehabilitation of the patient. Patients receive group-based health education provided by nursing professionals during these sessions.These rehabilitation sessions are typically completed within three months following the coronary event. Patients continue to receive medical and nursing attention through specialized care centers or primary care. Both groups receive optimal pharmacological treatment and general advice on cardiovascular health, including physical activity and diet.

06

What researchers measure

Primary outcomes

  1. Cardiac Self-Efficacy

    His measure evaluates specific behaviors related to cardiovascular health using the Spanish-validated version of the Cardiac Self-Efficacy Scale (S-CSE). This tool consists of 12 items across three dimensions: symptom control, disease control, and activity maintenance. Each item is rated on a 7-point Likert scale (1 = not at all confident, 7 = completely confident). Total scores range from 12 to 84, where higher scores indicate better self-efficacy

    Time frame: Experimental Group: measured at two time points: baseline (during hospitalization) and 8 months (post-coronary event). Control Group: measured only at the 8-month mark post-coronary event to evaluate the level of self-efficacy after receiving standard

Secondary outcomes

  1. Adherence to the Mediterranean Diet

    Measured using the MEDAS questionnaire (14 items). Higher scores indicate greater adherence to a heart-healthy diet

    Time frame: Experimental Group: baseline and 8 months Control Group: 8 months only

  2. Nicotine Dependence

    Assessed using the Fagerström Test (6 items). Scores range from 0 to 10, where greater than or equal to 7 indicates high dependence

    Time frame: Experimental Group: baseline and 8 months Control Group: 8 months only

  3. Motivation to Quit Smoking

    Evaluated through the Richmond Test (4 items). Scores range from 0 to 10; scores between 8-10 indicate high motivation.

    Time frame: Experimental Group: Baseline and 8 months . Control Group: 8 months only.

  4. Physical Activity Level

    Measured using the International Physical Activity Questionnaire (IPAQ). It categorizes patients into high, moderate, or low activity levels based on METs.

    Time frame: Experimental Group: Baseline and 8 months Control Group: 8 months only.

  5. Affective State (Anxiety and Depression)

    Determined using the Goldberg Scale. It consists of two subscales (anxiety mayor o igual a 4 and depression greater than or equal to 2) to detect psychological distress

    Time frame: Experimental Group: Baseline and 8 months Control Group: 8 months only

  6. Lipid Profile

    Clinical data collection of total cholesterol, LDL, HDL, and triglycerides from medical records

    Time frame: Experimental Group: Baseline and 8 months Control Group: 8 months only

  7. Cardiac Rehabilitation Adherence

    Exploration of patient inclusion, adherence (number of sessions attended), and group education received

    Time frame: 8 months (for both groups)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Currently, there is no plan to share individual participant data (IPD) with external researchers or public platforms. According to the protocol, the collected data will be used exclusively for the research purposes of this specific study, and only the research team will have access to the anonymized database. Patient privacy is protected by current regulations (Spanish Organic Law 3/2018), ensuring that information is treated confidentially and securely within the hospital environment.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2026 (actual). Primary completion is estimated for Jan 2027, 11 months after the start.

Of 322 non-industry interventional studies with no phase under Myocardial Infarction, half reached primary completion within 36 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 58. This study's planned 11 months is below that.

Counting every sponsor, half of 355 studies reached it within 34 months; a quarter within 15 and three quarters within 57.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 28, 2026
First posted
Feb 11, 2026
StartActual
Jan 12, 2026
Primary completionEst.
Jan 1, 2027
CompletionEst.
Jan 1, 2027
Last update
Feb 11, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07402642
Lead sponsor
Sergio Mies Padilla
Collaborators
Complejo Hospitalario Universitario Insular Materno Infantil
Responsible party
Sergio Mies Padilla (Nurse doctor in the research support unit, Servicio Canario de Salud) — Sponsor-investigator
First posted
Feb 11, 2026
Start date
Jan 12, 2026
Primary completion
Jan 1, 2027 (estimated)
Completion
Jan 1, 2027 (estimated)
Last update
Feb 11, 2026

Study contacts

Sergio Mies Padilla
Contact
smiepad@gobiernodecanarias.org
+34928478880
Cristina María Torres Moreno
Contact
isocrimi@gmail.com
+34928444000 (ext:71363)

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion